{"id":"https://genegraph.clinicalgenome.org/r/d17d4f67-7edd-4c44-a43b-9690be05e26fv1.6","type":"EvidenceStrengthAssertion","dc:description":["*NLGN3* was first reported in relation to X-linked complex neurodevelopmental disorder in 2003 (Jamain et al., PMID: 12669065). *NLGN43* encodes a member of the neuroligin family of neuronal cell-adhesion molecules that are localized postsynaptically, interact with presynaptic neurexins, and play a key role in the maturation and function of synapses. *NLGN3* variants have been identified in males with autism, intellectual disability, learning disability, or seizures. Carrier females are unaffected. Variants in *NLGN3* were curated under the disease entity complex neurodevelopmental disorder. A truncating variant reported in an individual with schizophrenia (PMID: 24126926) was not included in this curation.\n\nFour variants (nonsense, frameshift, and missense) that have been reported in five probands in four publications (PMIDs: 12669065, 25167861, 25533962, 28263302) are included in this curation. Variants in this gene segregated with disease in two additional family members. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by mouse models and *in vitro* functional studies that underscore a critical role of NLGN3 in synaptic transmission. \n\nIn summary, there is moderate evidence supporting the relationship between *NLGN3* and X-linked complex neurodevelopmental disorder. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 15, 2018 (SOP Version 5). As of October 2025, this record underwent administrative updates to include an evidence summary text and update scoring to be consistent with SOP Version 11. No new evidence was added.","*NLGN3* was first reported in relation to X-linked complex neurodevelopmental disorder in 2003 (Jamain et al., PMID: 12669065). *NLGN43* encodes a member of the neuroligin family of neuronal cell-adhesion molecules that are localized postsynaptically, interact with presynaptic neurexins, and play a key role in the maturation and function of synapses. *NLGN3* variants have been identified in males with autism, intellectual disability, learning disability, or seizures. Carrier females are unaffected. Variants in *NLGN3* were curated under the disease entity complex neurodevelopmental disorder. A truncating variant reported in an individual with schizophrenia (PMID: 24126926) was not included in this curation.\n\nFour variants (nonsense, frameshift, and missense) that have been reported in five probands in four publications (PMIDs: 12669065, 25167861, 25533962, 28263302) are included in this curation. Variants in this gene segregated with disease in two additional family members. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by mouse models and *in vitro* functional studies that underscore a critical role of NLGN3 in synaptic transmission. \n\nIn summary, there is moderate evidence supporting the relationship between *NLGN3* and X-linked complex neurodevelopmental disorder. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 15, 2018 (SOP Version 5). As of October 2025, this record underwent administrative updates to include an evidence summary text and update scoring to be consistent with SOP Version 11. No new evidence has been added."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d17d4f67-7edd-4c44-a43b-9690be05e26f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2018-08-15T10:00:00.000Z","2018-08-14T22:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-10-24T10:08:55.105Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71aa2111-5f30-4950-ad89-1b454b585ee3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25167861","rdfs:label":"Family Figure S20","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/71aa2111-5f30-4950-ad89-1b454b585ee3","type":"Family","rdfs:label":"Family Figure S20","member":{"id":"https://genegraph.clinicalgenome.org/r/f394cc3e-9333-4cb0-b134-573be145eef2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25167861","rdfs:label":"APN-99","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3817fbb3-b895-4e40-855a-e8aadaccd5c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_181303.2(NLGN3):c.1849C>T (p.Arg617Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/235850"}},"detectionMethod":"Targeted high-throughput sequencing of 217 genes in which mutations have been reported in patients with ID or autism.","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0010864","obo:HP_0002360","obo:HP_0001344","obo:HP_0000717"],"previousTesting":true,"previousTestingDescription":"Fragile-X test was negative. Array-CGH showed a deletion 5q15 inherited from the father. Karyotype was normal.","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6bc8cb8b-3474-4a6a-b5cf-0e3afd003f78_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25167861","allele":{"id":"https://genegraph.clinicalgenome.org/r/3817fbb3-b895-4e40-855a-e8aadaccd5c3"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0010864","obo:HP_0000717"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f394cc3e-9333-4cb0-b134-573be145eef2"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/51bc4801-e52b-44d9-95fa-4c1b1188897d_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 2 affected individuals in this family","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12669065","rdfs:label":"Family Figure 2b","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/51bc4801-e52b-44d9-95fa-4c1b1188897d","type":"Family","rdfs:label":"Family Figure 2b","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/4a6fcb41-eddf-4240-9cb8-b717c103f145","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12669065","rdfs:label":"II-1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6a454d5e-8469-465e-8c00-51ce5587ffe1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_181303.2(NLGN3):c.1411C>T (p.Arg471Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/11327"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Variant also present in the brother with Asperger syndrome.","phenotypes":["obo:HP_0000717","obo:HP_0010864","obo:HP_0002069"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bb26161d-05e2-4bc1-ba62-4a1fc6436d08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12669065","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a454d5e-8469-465e-8c00-51ce5587ffe1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0000717","proband":{"id":"https://genegraph.clinicalgenome.org/r/4a6fcb41-eddf-4240-9cb8-b717c103f145"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6bc8cb8b-3474-4a6a-b5cf-0e3afd003f78","type":"EvidenceLine","dc:description":"The proband inherited a 5q15del from his father. The NR2F1 gene at the 5q15 locus has been associated with ID and/or ASD (Bosch-Boonstra-Schaaf optic atrophy syndrome). Given that his maternal cousin with ID and ASD had the same missense variant and did not share the 5q15del, this case was awarded 0.1 points (the default score for missense variants without functional evidence of pathogenicity).","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6bc8cb8b-3474-4a6a-b5cf-0e3afd003f78_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bb26161d-05e2-4bc1-ba62-4a1fc6436d08","type":"EvidenceLine","dc:description":"The missense variant was shown to result in loss of function.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb26161d-05e2-4bc1-ba62-4a1fc6436d08_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bb26161d-05e2-4bc1-ba62-4a1fc6436d08_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Using in vitro transfection studies, Comoletti et al. (2004, PMID: 15152050) showed that the R451C mutation resulted in defective neuroligin trafficking and retention of the mutant protein in the endoplasmic reticulum. The small amount of mutant protein that reached the cell membrane demonstrated diminished binding activity for neurexin-1, consistent with a loss of function. Additional evidence of pathogenicity for this variant was scored as experimental evidence.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f5c35cdf-0c8a-42ba-9dbe-ec4af740971c","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5c35cdf-0c8a-42ba-9dbe-ec4af740971c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25533962","allele":{"id":"https://genegraph.clinicalgenome.org/r/45e88133-0d71-4914-bcae-a2f7711a2779","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_181303.1(NLGN3):c.1448G>A (p.Trp483Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA413562869"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ce0f0263-b7ee-44cb-8540-5dbf3c07b730","type":"EvidenceLine","dc:description":"Score downgraded because it is unclear if the two patients reported in this publication with the same frameshift variant belong to the same family.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce0f0263-b7ee-44cb-8540-5dbf3c07b730_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28263302","allele":{"id":"https://genegraph.clinicalgenome.org/r/45154aa6-8e8a-4aef-9576-df15c988cf43","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_181303.1(NLGN3):c.1408dup (p.Arg470ProfsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658820793"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.75},{"id":"https://genegraph.clinicalgenome.org/r/1c3d0bed-d106-4f13-af1f-02e6aadfb1b2","type":"EvidenceLine","dc:description":"Score downgraded because it is unclear if the two patients reported in this publication with the same frameshift variant belong to the same family. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c3d0bed-d106-4f13-af1f-02e6aadfb1b2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28263302","allele":{"id":"https://genegraph.clinicalgenome.org/r/45154aa6-8e8a-4aef-9576-df15c988cf43"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.75}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":4.6},{"id":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e8a6e7e-f814-4a14-8718-b10c09c01828","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14b55557-25e3-4d1a-a774-0112ed472fa3","type":"Finding","dc:description":"Binding studies showed that neuroligins Nlgn1, Nlgn2, and Nlgn3 bind to the Î²-neurexin isoform of the three neurexins (Nrxn1, Nrxn2, and Nrxn3). Neurexins are neuronal cell surface proteins that play an important role in synaptic transmission. Loss-of-function variants and deletions in NRXN1 have been implicated in ASD and other neurodevelopmental disorders. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8576240","rdfs:label":"Interaction with neurexins","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/30af40a3-509c-4565-acbc-947805cb31cd","type":"EvidenceLine","dc:description":"Evidence not scored because Nlgn1 or Nlgn2 were used as baits instead of Nlgn3","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42ae19a1-b023-403c-8f6f-5a7663ef9a92","type":"Finding","dc:description":"A yeast two-hybrid screen showed that neuroligins (Nlgn1 and Nlgn2) bind to multiple PDZ domain-containing proteins, including several that have been implicated in neurodevelopmental disorders, such as PSD95 (gene DLG4), SAP102 (gene DLG3), and SHANK3.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15458844","rdfs:label":"Interaction with PDZ domain-containing proteins","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa006b62-a197-4b94-9501-0760774282f6","type":"EvidenceLine","dc:description":"The intracellular retention of the R451C mutant protein in the endoplasmic reticulum was already scored as variant evidence (Comoletti et al., 2004, PMID: 15152050), and as experimental evidence (Chih et al., 2004, PMID: 15150161).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48bd8e6b-98b0-40af-898e-16e85dfcf926","type":"FunctionalAlteration","dc:description":"The NLGN3 R451C variant reported in ASD results in endoplasmic reticulum (ER) retention of the mutant protein in transfected HEK293 cells. ER chaperones show more association with the mutant protein, and the mutant protein is more sensitive to protease cleavage. In hippocampal neurons, the mutation compromises neuronal trafficking of the protein and reduces the export of NLGN3 from the soma to the dendritic spines.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20615874","rdfs:label":"R451C trafficking deficiency"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/ae95bcef-8c40-4778-a9f5-7da054fdc330","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99d5cb48-67b9-4893-9ed5-ef2cbfbf678f","type":"FunctionalAlteration","dc:description":"This study explored the consequences of the missense variant reported by Jamain et al. (2003, PMID: 12669065) in two brothers with autism (NM_181303.2:c.1411C>T, p.Arg471Cys, referred to here as R451C). In transfected COS cells, the variant resulted in intracellular retention of the mutant protein in the endoplasmic reticulum. Because NLGNs are transmembrane proteins, this intracellular retention leads to loss of function. Rat hippocampal neurons were transfected with R451C mutant or wild type NLGN3. While wild type NLGN3 stimulated the formation of presynaptic terminals, cells transfected with the mutant form lost this synapse-promoting activity, and had significantly decreased number of synapsin-positive puncta. Synaptic formation plays an important role in neurodevelopment and the etiology of autism and other neurodevelopmental disorders.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15150161","rdfs:label":"Functional study p.Arg471Cys"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.75},{"id":"https://genegraph.clinicalgenome.org/r/b6e7e531-093b-4216-8c56-0c94e63c2811_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79285fd5-22cd-4e7b-bf0a-f330b2c28260","type":"EvidenceLine","dc:description":"Note that this mouse model (Tabuchi et al., 2008, PMID: 17823315) is different from the KI mouse model in Chadman et al. (2008).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe4ae58d-160d-4632-8f5c-2c214bc211e5","type":"Finding","dc:description":"Nlgn3 R451C knock-in mice, first reported by Tabuchi et al. (2008, PMID: 17823315), exhibit impaired social behaviors, increased synaptic inhibition in the somatosensory cortex and enhanced excitatory synaptic transmission in the hippocampus. Nlgn3 KI mice also exhibit up-regulation of NMDA receptors containing NR2B subunits and enhanced long-term potentiation in the hippocampus. Nlgn3 KO mice do not exhibit any of these changes. The R451C mutation also increased dendritic branching and altered the structure of synapses in the hippocampus. These findings suggest that Nlgn3 controls excitatory and inhibitory synapse properties in a region- and circuit-specific manner.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21808020","rdfs:label":"Another R451C KI mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fea50201-a3d9-41c2-a4a0-1ef74a13faf0","type":"EvidenceLine","dc:description":"No autism-like or cognitive deficits were found in this model.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4521421f-6d0c-427b-a695-54d02afebe45","type":"Finding","dc:description":"Knockin mouse with the Nlgn3 R451C missense variant reported by Jamain et al. (2003, PMID: 12669065) in two brothers with autism (p.Arg471Cys, referred to here as R451C). No differences were detected between Nlgn3 KI mice and their wildtype littermates on a battery of behavioral tests, including social interaction, cognitive abilities, sensory abilities, sensorimotor gating, motor functions, and anxiety-related traits. Minor developmental differences were detected between Nlgn3 and WT, including slower righting reflexes at postnatal days 2-6, and less vocalizations on postnatal day 8. Nlgn3 adults exhibited longer latencies to fall from the rotarod, less vertical activity in the open field, and less acoustic startle to high decibel tones.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19360662","rdfs:label":"R451C KI mice - behavior","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/1d68a3b5-2d03-46ab-9b04-7e03734cb779","type":"EvidenceLine","dc:description":"The score was downgraded due to the limited scope of the behavioral analyses performed.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb524293-840f-444e-9699-c6a1f93ed6ec","type":"Finding","dc:description":"Nlgn3 knockout rats exhibit decreased juvenile play and decreased wood block chewing behavior at night.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24773431","rdfs:label":"Nlgn3 KO rat","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/83876e89-d41c-4309-ab00-fca0746b211f","type":"EvidenceLine","dc:description":"Learning ability in this KO mouse model was not significantly different from WT. Cannot rule out possibility of olfactory deficit confounding the decreased social novelty preference phenotype.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4e6f16b8-278a-45e0-b3fc-393e68416b98","type":"Finding","dc:description":"Nlgn3 knockout mice displayed reduced ultrasound vocalization and lack of social novelty preference. The latter may be related to an olfactory deficiency observed in Nlgn3 mutants. Nlgn3 KO mice also exhibited increased locomotor activity, but had no clear deficits in learning and memory. The total brain volume of Nlgn3-deficient mice was slightly reduced, as determined by magnetic resonance imaging.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19243448","rdfs:label":"Nlgn3 KO mice - behavior","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.25}],"evidenceStrength":"Moderate","sequence":12103,"specifiedBy":"GeneValidityCriteria11","strengthScore":9.85,"subject":{"id":"https://genegraph.clinicalgenome.org/r/XzU5WNiRTOg","type":"GeneValidityProposition","disease":"obo:MONDO_0100148","gene":"hgnc:14289","modeOfInheritance":"obo:HP_0001417"},"version":"1.6","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_b6e7e531-093b-4216-8c56-0c94e63c2811-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}